摘要
目的探讨改良森田疗法对康复期精神分裂症患者生活质量的影响。方法将119例18~60岁,病程≥3年,进入康复期≥1月,PAN SS评分≤28分,符合美国精神障碍诊断和统计标准第4版(DSMⅣ)的精神分裂症患者,随机分为研究组和对照组。两组在常规药物治疗的同时分别合并改良森田疗法训练(研究组)和基本康复训练(对照组),6周前后两组分别进行简明精神障碍评定量表(BPRS)和精神分裂症病人生活质量量表(SQLS)评定。结果入组时两组BPRS、SQLS测评无差异(t=1.093,0.118)。6周后两组BPRS总分无差异((t=1.865),两组训练治疗前后BPRS总分有显著性差异((t=8.980,5.862);研究组6周前后SQLS评分有显著性差异((t=2.644),对照组无差异((t=0.243);两组6周后SQLS评分有显著性差异((t=2.741)。结论改良森田疗法明显改善康复期精神分裂症患者的生活质量,值得临床推广。
Objective To explore the effects of Modified Morita Therapy on the quality of life (QOL) of convalescent patients with schizophrenia. Methods 119 18-60years old patients with schizophrenia who met the diagnostic criteria of DSM-Ⅳ and CCMD-3 were randomly divided into study group and control group. Both groups were treated with routine medicatiort and combined with Modified Morita Therapy and basic rehabilitation training respectively, pre and post treatment, both groups were assessed with BPRS and SQLS. Results Pre-treatment, there was no difference on BPRS and SQLS in the two groups ((t= 1. 093, 0. 118). 6 weeks later, there was no difference on BPRS between two groups(t= 1. 865), however, there were significant differences between pre and post-treatment on BPRS in the two groups ((t= 8. 980, 5. 862), 3. 811); there vcere significant differences between pre and post-treatment on SQLS in the study group ((t= 2. 644) and no differences in the control group((t= 0. 243); there were significant differences between the two groups on SQLS((t=2. 741). Conclusion Modified Morita Therapy can obviously improve the quality of life (QOL) of convalescent patients with schizophrenia.
出处
《中国健康心理学杂志》
2009年第5期525-526,共2页
China Journal of Health Psychology
关键词
改良森田疗法
生活质量
精神分裂症
康复期患者
Modified morita therapy
Quality of life
Schizophrenia
Convalescent patient